Neurologists are warning that popular weight-loss medications could have severe negative effects on neurodegenerative conditions like ALS.
Jinsy Andrews, MD, a neurologist and director of NYU Langone’s ALS Center, says the very mechanism that makes these drugs popular — rapid weight loss — can go against the biological needs of patients with neuromuscular disorders.
GLP-1 agonists have shown to be highly effective at managing diabetes and obesity, which are major health concerns across the population.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
